This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Canine Atrial Natriuretic Peptide (ANP) ELISA Kit-Competitive
Product Overview
BioVenic Canine Atrial Natriuretic Peptide (ANP) ELISA Kit-Competitive is designed for the quantitative determination of Canine Atrial Natriuretic Peptide (ANP) in serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids using a Competitive ELISA method. For research use only.
Specifications
Target Information
Atrial natriuretic peptide (ANP) exerts its natriuretic effects in the kidney and vasodilatory effects on general vessels, which may lead to therapeutic effects in heart failure. It is mainly secreted and stored in atrial myocytes and released by atrial wall stretch, the action of ANP can be considered as a cardioprotective effect initiated by the heart itself, especially in the condition of heart failure. Research has shown that ANP suppresses acute atrial electrical remodeling in the canine rapid atrial pacing model.
Shipping and Storage
This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.